logo
Scientists Identify a Trait in Speech That Foreshadows Cognitive Decline

Scientists Identify a Trait in Speech That Foreshadows Cognitive Decline

Yahoo4 days ago
Early signs of Alzheimer's disease may be hidden in the way a person speaks, but it's not yet clear which details of our diction are most critical for diagnosis.
A study from 2023 suggests that as we age, how we say something may matter more than what we say. Researchers at the University of Toronto think the pace of everyday speech may be a better indicator of cognitive decline than difficulty finding a word.
Lethologica, also known as 'tip of the tongue' phenomenon, is experienced by young and old alike. But as we grow older, finding the name for things can become more challenging, especially over the age of 60.
To explore why that is, researchers at the University of Toronto asked 125 healthy adults, between the ages of 18 and 90, to describe a scene in detail.
Related:
Next, the participants were shown pictures of everyday objects while listening to audio that was designed to confirm or confuse them.
For instance, if participants were shown a picture of a broom, the audio might say 'groom', which helps them recall the word through rhyme. But on the flip side, the audio might also offer a related word like 'mop', which can lead the brain astray, momentarily.
The faster a person's natural speech in the first task, the more quickly they came up with answers in the second task.
The findings align with the 'processing speed theory', which argues that a general slowdown in cognitive processing lies at the very center of cognitive decline, not a slowdown in memory centers specifically.
"It is clear that older adults are significantly slower than younger adults in completing various cognitive tasks, including word-production tasks such as picture naming, answering questions, or reading written words," explained a team led by University of Toronto psychologist Hsi T. Wei.
"In natural speech, older adults also tend to produce more dysfluencies such as unfilled and filled pauses (e.g., "uh" and "um") in between speech and have a generally slower speech rate."
In a 2024 piece for The Conversation, dementia researcher Claire Lancaster said that the study from Toronto "has opened exciting doors… showing that it's not just what we say but how fast we say it that can reveal cognitive changes."
Recently, some AI algorithms have even been able to predict an Alzheimer's diagnosis with an accuracy of 78.5 percent using speech patterns alone.
Other studies have found that patients with more signs of amyloid plaque in their brain are 1.2 times more likely to show speech-related problems.
Amyloid plaques are a hallmark of Alzheimer's disease.
In 2024, researchers at Stanford University led a study that found longer pauses and slower speech rates were also associated with higher levels of tangled tau proteins, another hallmark of Alzheimer's.
Related:
"This suggests that speech changes reflect development of Alzheimer's disease pathology even in the absence of overt cognitive impairment," the authors of the study concluded.
The groundwork is still being laid, but scientists are getting closer to decoding the nuances of human speech to figure out what our words are saying about our brains.
The 2023 study was published in Aging, Neuropsychology, and Cognition.
Massive 16-Year Study Links Wellbeing to Stronger Memory in Aging
Your Brain's Youthfulness (or Lack of It) Could Predict How Long You Live
This Foot Scan Could Stop Your Small Cut From Costing You a Limb
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GSK's Blood Cancer Drug Blenrep Fails to Win FDA Panel Support
GSK's Blood Cancer Drug Blenrep Fails to Win FDA Panel Support

Bloomberg

time27 minutes ago

  • Bloomberg

GSK's Blood Cancer Drug Blenrep Fails to Win FDA Panel Support

GSK Plc's blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting its approval in doubt. The US Food and Drug Administration 's Oncologic Drugs Advisory Committee voted that the risks from the drug, called Blenrep, outweighed its benefits. Panelists voted 5-to-3 against a combination of Blenrep and the generic cancer drug Velcade and 7-to-1 against the drug in tandem with Pomalyst, marketed by Bristol Myers Squibb Co.

Medical waste found on P.E.I. property not believed to have any criminal aspect, RCMP say
Medical waste found on P.E.I. property not believed to have any criminal aspect, RCMP say

Yahoo

timean hour ago

  • Yahoo

Medical waste found on P.E.I. property not believed to have any criminal aspect, RCMP say

The RCMP says there's no indication that a small pile of unsecured medical waste found on a rural property in eastern P.E.I. has any criminal aspect. In an email to CBC News Thursday, the RCMP said the provincial Department of Environment, Energy and Climate Action asked them to conduct a review of the waste and how it got to the vacant land near Murray River. "Our conclusion is that there is no information to suggest there is a criminal act or intent," the email reads. "RCMP will not be further involved in this, and we have no interest in the items recovered." Police say the property owners contracted a third-party service to clean up the waste. Earlier this month, CBC News reported on the discovery of what appeared to be vials of blood, testing strips and other medical waste.. The land is owned by Moonlight International Foundation, a non-profit with ties to the Buddhist community in the province. Photos obtained by CBC News via drone showed the materials in a loose pile on the ground. Some of the material had writing in Chinese characters. The Department of Environment, Energy and Climate Action confirmed staff had inspected the area on July 9, and said the amount of waste they found would fit into a small garbage bag. A spokesperson for the Moonlight International Foundation said in an email that the group had learned about the medical waste through correspondence with CBC News, calling it "truly a regrettable situation." Under the P.E.I. Environmental Protection Act's waste resource management regulations, no person can dispose of special waste, which includes medical waste, except at an appropriate landfill or composting facility that's approved to accept the material.

Waud Capital Partners Forms New Partnership with Experienced Healthcare Executive Bill Mixon
Waud Capital Partners Forms New Partnership with Experienced Healthcare Executive Bill Mixon

Yahoo

timean hour ago

  • Yahoo

Waud Capital Partners Forms New Partnership with Experienced Healthcare Executive Bill Mixon

Waud Capital Partners teams up with accomplished industry executive to acquire and build a healthcare supply chain solutions company CHICAGO, July 17, 2025 /PRNewswire/ -- Waud Capital Partners ("Waud Capital"), a growth-oriented middle-market private equity firm, announced today that it has formalized an executive partnership with Bill Mixon to pursue a platform investment in the medical device and supply chain services market. Targeted sub-sectors of focus will include but are not limited to home distribution, other value-add specialty distribution, outsourced provider equipment services, and chronic care and population health management offerings that deliver value to supply chain channel partners. Waud Capital anticipates investing over $100 million of equity capital to support the initiative. Mr. Mixon is an accomplished healthcare executive with more than 30 years of operating experience across the medical device and supply chain services continuum, with particular emphasis on specialty distribution and outsourced provider equipment services. He brings deep operational expertise with an extensive focus on enhancing clinical value and improving patient outcomes through the medical supply chain. Mr. Mixon has successfully scaled several private equity-backed and publicly traded organizations through repeatable organic growth strategies as well as strategic acquisitions. Most recently, Mr. Mixon served as Chief Executive Officer of Advanced Diabetes Supply, where he led the organization through a successful sale from its private equity sponsor to Cardinal Health. Advanced Diabetes Supply is a national diabetes care management platform distributing innovative therapies including continuous glucose monitors and other diabetes-related supplies. During his time at Advanced Diabetes Supply, Mr. Mixon drove transformational growth by professionalizing the organization through salesforce productivity enhancements, executing a shift in go-to-market initiatives, and delivering margin improvements through revenue cycle initiatives and other operational efficiencies. At time of sale to Cardinal Health, Advanced Diabetes Supply had grown to $1B in revenue and served nearly a half-million patients annually. Prior to Advanced Diabetes Supply, Mr. Mixon was the Chief Executive Officer of National Seating & Mobility, a provider of comprehensive mobility solutions to patients in the home. Under Mr. Mixon's leadership at National Seating & Mobility, the organization scaled through organic and inorganic methods and successfully transacted on several different occasions to multiple private equity sponsors. Mr. Mixon began his career with the U.S. Army before holding leadership positions at large organizations such as Baxter, Phillips, and Agiliti Health. "I'm excited to partner with Waud Capital to identify and help build what we hope will be an industry-leading business that supports and improves the overall healthcare supply chain," said Mr. Mixon. "Waud Capital's executive partnership approach, dedicated ecosystem resources, and deep investing experience across relevant areas make the firm a highly attractive partner. I believe this combination will enable us to capitalize on transformative growth opportunities, and I look forward to leveraging my past experiences to drive clinical value for medical professionals, manufacturers, payors and most importantly, patients." "We are thrilled to partner with Bill," said Mike Lehman, Principal at Waud Capital. "He is an exceptional executive who has created value and driven multiple successful outcomes throughout his career in a sector we find highly attractive. The healthcare supply chain markets are highly fragmented with significant opportunities for organizations to deliver value-add solutions and address substantial challenges for key stakeholders." This executive partnership builds upon Waud Capital's extensive experience investing across the broader healthcare supply chain services and home care markets. Notable investments include Mopec Group (supplier of pathology equipment, consumables and services), PromptCare (home infusion and durable medical equipment), Provider Network Holdings (specialty medication supply management), DS Medical (home medical supplies), and recent home care investments AltoCare (in-home senior care), and Concierge Home Care (skilled home healthcare). "The partnership with Bill is another example of Waud Capital's executive-first campaign approach and commitment to support accomplished executive leaders with the full ecosystem of resources to execute transformative growth strategies in large, growing markets," said Kyle Lattner, Partner at Waud Capital. "This is our second dedicated campaign in the medical device and supply chain services market in the last two years and we are thrilled about the prospects of what we can accomplish during our partnership with Bill." About Waud Capital PartnersBased in Chicago and founded by Reeve B. Waud, Waud Capital Partners is a growth-oriented private equity firm with over 30 years of investing experience. Waud Capital Partners seeks to partner with experienced management teams to build market-leading companies within two industries: healthcare and software & technology. Since its founding in 1993, Waud Capital has successfully completed more than 500 investments, including platform companies and follow-on opportunities. For additional information on Waud Capital, please visit Investment Professional Contacts:Kyle Lattner, Partner(312) 676-8404klattner@ Mike Lehman, Principal(312) 676-8446mlehman@ Business Development Contact:Phil Olson, Partner – Business Development(312) 676-8401polson@ Investor Relations Contact:Jessica Schmitt, Head of Investor Relations(312) 676-8400jschmitt@ View original content to download multimedia: SOURCE Waud Capital Partners

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store